Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Florian M. Wagenlehner & Jakhongir F. Alidjanov. (2016) Efficacy, pharmacokinetic and pharmacodynamic profile of ceftolozane + tazobactam in the treatment of complicated urinary tract infections. Expert Opinion on Drug Metabolism & Toxicology 12:8, pages 959-966.
Read now
Read now
Karen Bush & Mark J Macielag. (2010) New β-lactam antibiotics and β-lactamase inhibitors. Expert Opinion on Therapeutic Patents 20:10, pages 1277-1293.
Read now
Read now
Articles from other publishers (20)
Raul Velez-Montoya, Luz Monroy-Esquivel, Rocío Ortiz-Guevara, Hugo Quiroz-Mercado & Jans Fromow-Guerra. (2023) ALTERNATIVE INTRAVITREAL ANTIBIOTICS. Retina 43:9, pages 1433-1447.
Crossref
Crossref
Kamran Banan, Dara Hatamabadi, Hanif Afsharara, Bahar Mostafiz, Hadise Sadeghi, Soheil Rashidi, Amirreza Dowlati Beirami, Mohammad-Ali Shahbazi, Rüstem Keçili, Chaudhery Mustansar Hussain & Fatemeh Ghorbani-Bidkorbeh. (2022) MIP-based extraction techniques for the determination of antibiotic residues in edible meat samples: Design, performance & recent developments. Trends in Food Science & Technology 119, pages 164-178.
Crossref
Crossref
Donald J. AbrahamSebastian A. Testero, Leticia I. Llarrull, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
188
.
Lisa M. Miller, Reyme Herman, Ivan Gyulev, Thomas F. Krauss, Gavin H. Thomas & Anne-Kathrin Duhme-Klair. (2020) Synthesis and biochemical evaluation of cephalosporin analogues equipped with chemical tethers. RSC Advances 10:60, pages 36485-36494.
Crossref
Crossref
Nilanjana Das, Jagannathan Madhavan, Adikesavan Selvi & Devlina Das. (2019) An overview of cephalosporin antibiotics as emerging contaminants: a serious environmental concern. 3 Biotech 9:6.
Crossref
Crossref
Allana J. Sucher, Elias B. Chahine, Peter Cogan & Matthew Fete. (2015) Ceftolozane/Tazobactam. Annals of Pharmacotherapy 49:9, pages 1046-1056.
Crossref
Crossref
Aurélie Mélard, Laetitia G. Garcia, Debaditya Das, Raoul Rozenberg, Paul M. Tulkens, Françoise Van Bambeke & Sandrine Lemaire. (2013) Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin. Journal of Antimicrobial Chemotherapy 68:3, pages 648-658.
Crossref
Crossref
Rúben Fernandes, Paula Amador & Cristina Prudêncio. (2013) β-Lactams. Reviews in Medical Microbiology 24:1, pages 7-17.
Crossref
Crossref
Malcolm G. P. Page. 2012. Antibiotic Discovery and Development. Antibiotic Discovery and Development
79
117
.
Darpan Kaushik, Sudeep Rathi & Ankit Jain. (2011) Ceftaroline: a comprehensive update. International Journal of Antimicrobial Agents 37:5, pages 389-395.
Crossref
Crossref
Laura Freire-Moran, Bo Aronsson, Chris Manz, Inge C. Gyssens, Anthony D. So, Dominique L. Monnet & Otto Cars. (2011) Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now. Drug Resistance Updates 14:2, pages 118-124.
Crossref
Crossref
Lauren LimElizabeth SuttonJack Brown. (2011) Ceftaroline: A new broad-spectrum cephalosporin. American Journal of Health-System Pharmacy 68:6, pages 491-498.
Crossref
Crossref
Donald J. AbrahamSebastian A. Testero, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
257
402
.
Leticia I. Llarrull, Jed F. Fisher & Shahriar Mobashery. (2009)
Molecular Basis and Phenotype of Methicillin Resistance in
Staphylococcus aureus
and Insights into New β-Lactams That Meet the Challenge
. Antimicrobial Agents and Chemotherapy 53:10, pages 4051-4063.
Crossref
Crossref
Sandrine Lemaire, Youri Glupczynski, Valérie Duval, Bernard Joris, Paul M. Tulkens & Françoise Van Bambeke. (2009)
Activities of Ceftobiprole and Other Cephalosporins against Extracellular and Intracellular (THP-1 Macrophages and Keratinocytes) Forms of Methicillin-Susceptible and Methicillin-Resistant
Staphylococcus aureus
. Antimicrobial Agents and Chemotherapy 53:6, pages 2289-2297.
Crossref
Crossref
George G. Zhanel, Grace Sniezek, Frank Schweizer, Sheryl Zelenitsky, Philippe R.S. Lagacé-Wiens, Ethan Rubinstein, Alfred S. Gin, Daryl J. Hoban & James A. Karlowsky. (2009) Ceftaroline. Drugs 69:7, pages 809-831.
Crossref
Crossref
K. Yoganathan, Shugeng Cao, Sharon C. Crasta, Srinivasulu Aitipamula, Stephen R. Whitton, Siewbee Ng, Antony D. Buss & Mark S. Butler. (2008) Microsphaerins A–D, four novel benzophenone dimers with activity against MRSA from the fungus Microsphaeropsis sp.. Tetrahedron 64:44, pages 10181-10187.
Crossref
Crossref
X. H. Ma, R. Wang, S. Y. Yang, Z. R. Li, Y. Xue, Y. C. Wei, B. C. Low & Y. Z. Chen. (2008) Evaluation of Virtual Screening Performance of Support Vector Machines Trained by Sparsely Distributed Active Compounds. Journal of Chemical Information and Modeling 48:6, pages 1227-1237.
Crossref
Crossref
Sandrine Lemaire, Cosimo Fuda, Françoise Van Bambeke, Paul M. Tulkens & Shahriar Mobashery. (2008) Restoration of Susceptibility of Methicillin-resistant Staphylococcus aureus to β-Lactam Antibiotics by Acidic pH. Journal of Biological Chemistry 283:19, pages 12769-12776.
Crossref
Crossref
Mark S. Butler. (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Natural Product Reports 25:3, pages 475.
Crossref
Crossref